Figure 2From: Disease control and functional outcome in three modern combined organ preserving regimens for locally advanced squamous cell carcinoma of the head and neck (SCCHN)Locoregional progression-free survival. 1: RChT; 2: RIT. RChT (n = 38), RIT (n = 38). RChT @ 2 years: 53.7%. RIT @ 2 years: 60.0%. Log-rank/Wilcoxon ns.Back to article page